Colorectal cancer care in elderly patients: Unsolved issues

Affiliation auteursAffiliation ok
TitreColorectal cancer care in elderly patients: Unsolved issues
Type de publicationJournal Article
Year of Publication2016
AuteursAparicio T, Pamoukdjian F, Quero L, Manfredi S, Wind P, Paillaud E
JournalDIGESTIVE AND LIVER DISEASE
Volume48
Pagination1112-1118
Date PublishedOCT
Type of ArticleReview
ISSN1590-8658
Mots-clésadjuvant therapy, Chemotherapy, Geriatric oncology, radiotherapy, Targeted therapy
Résumé

Colorectal cancers are common in elderly patients. However, cancer screening is poorly used after 75. Elderly patients form a heterogeneous population with specific characteristics. Standards of care cannot therefore be transposed from young to elderly patients. Tumour resection is frequently performed but adjuvant chemotherapy is rarely prescribed as there are no clearly established standards of care. In a metastatic setting, recent phase III studies have demonstrated that doublet front-line chemotherapy provided no survival benefit. Moreover, several studies have established the benefit of bevacizumab in association with chemotherapy. There is a lack of evidence for the efficacy of anti-epidermal growth factor antibodies in elderly patients. Geriatric assessments could help to select the adequate treatment strategy for individual patients. Geriatric oncology is now the challenge we have to face, and more specific trials are needed. (C) 2016 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

DOI10.1016/j.dld.2016.05.011